U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H48O6
Molecular Weight 504.6985
Optical Activity UNSPECIFIED
Defined Stereocenters 13 / 13
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MADECASSIC ACID

SMILES

[H][C@]12CC=C3[C@]4([H])[C@@H](C)[C@H](C)CC[C@@]4(CC[C@@]3(C)[C@]1(C)C[C@@H](O)[C@@]5([H])[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]25C)C(O)=O

InChI

InChIKey=PRAUVHZJPXOEIF-AOLYGAPISA-N
InChI=1S/C30H48O6/c1-16-9-10-30(25(35)36)12-11-28(5)18(22(30)17(16)2)7-8-21-26(3)13-20(33)24(34)27(4,15-31)23(26)19(32)14-29(21,28)6/h7,16-17,19-24,31-34H,8-15H2,1-6H3,(H,35,36)/t16-,17+,19-,20-,21-,22+,23-,24+,26-,27+,28-,29-,30+/m1/s1

HIDE SMILES / InChI

Description

Madecassic acid is a naturally produced terpene from Centella asiatica. It has demonstrated anti-inflammatory and anti-diabetic effects by blocking NF-kB activation and altering lipid metabolism in mice. Madecassic acid has also shown anti-tumor effects in a mouse model of colon cancer; and, was demonstrated in vitro to stimulate the growth of neurofilaments from rat PC1 cells.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
In a preclinical study, diabetic male Balb/cA mice were fed a diet including 0.05% and 0.1% madecassic acid by mass for six weeks.
Route of Administration: Oral
In Vitro Use Guide
Pheochromocytoma PC1 cells from rat adrenal medulla were maintained in Dulbecco's modified Eagle's medium. Madecassic acid at 40.8 uM was applied to PC12 cells for 72 hours on its own and in combination with 14.4 uM Asiatic acid. Madecassic acid showed moderate effects on neurofilament expression (monitored by microscopy). However, the combination delivered superior induction on the expression of NF68 and NF200 (monitored by western blot) compared to either on its own.